According to the latest study from BCC Research, "Global Cell Line and Membrane Market" is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by the end of 2030, at a compound ...

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

Researchers identified that triterpene glycosides from the starfish Solaster pacificus can kill drug-resistant prostate ...

We learn more about the CellCelector, its applications, how it overcomes the limitations of other instruments and top tips ...

Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs), announces the commercial release of ...

The Cell Culture Market presents strong growth opportunities, especially in regions like North America and Asia-Pacific where biopharmaceutical R&D ...

Patients must express PPARG in at least 60 percent of tumor cells to enroll in the trial and receive the investigational drug.

In this video interview, Michael Miller, chief operating officer at Quanterix, outlines key technical and regulatory ...

From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...

Promega and Aobious entered a settlement agreement to resolve a patent infringement lawsuit related to furimazine, a ...

Tumor cells rob other cells' mitochondria to energize their spread. For the first time, scientists discovered such theft from neurons.